Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and non-pregnant females at least 6 years of age~* History of recurrent unilateral or asymmetric non-infectious posterior uveitis of at east 1 year duration not associated with significant systemic activity of the disease~* The more severely affected eye having had at least 2 separate recurrences~* The more severely affected eye having been treated by systemic therapy for at least one month just before inclusion~* Visual acuity (VA) of at least 1.4 logMAR units at enrollment~* At time of enrollment, \</=10 anterior chamber cells/HPF and vitrous haze\</= grade 2.~Exclusion Criteria:~* known allergy or contraindication to fluocinolone acetonide, systemic corticosteroids, or the immunosuppressive agents to be administered~* history of retinal detachment, retinoschisis in the area of implantation, or media opacity precluding evaluation of the retina and vitreous~* presence or history of uncontrolled IOP while on steroid therapy resulting in loss of vision, or IOP \>25 mm Hg requiring at least 2 types of antiglaucoma medication to be reduced to \<25 mm Hg~* history of NIPU only or iritis only with no vitritis, macular edema, vitreous cells, or vitreous haze~* infectious etiology, vitreous hemorrhage, or a toxoplasma scar in the study eye~* ocular surgery and/or trauma on the study eye within 3 months prior to enrollment, or trabeculoplasty or yttrium aluminum garnet laser within 1 month prior to study enrollment~* monocularity~* AIDS~* pregnancy/lactation~* potential for noncompliance~* or participation in other clinical studies within 1 month of enrollment.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluocinolone acetonide (Type: EXPERIMENTAL): Intravitreal fluocinolone acetonide implant
- Standard care (Type: ACTIVE_COMPARATOR): Standard of Care

Based on this trial design, predict the completion outcome and termination type (if applicable).